This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignees: Km Biologics Co., Ltd., Kyoto University. Active years: 2023.
Company Filing History:
1 out of 24 
1 out of 859 
Years Active: 2023
Title: Toyonari Kubota: Innovator in Liver Damage Diagnostics
Introduction
Toyonari Kubota is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of medical diagnostics, particularly concerning liver health. His innovative work focuses on the use of ADAMTS13, a protein that plays a crucial role in monitoring liver conditions.
Latest Patents
Kubota holds a patent for a diagnostic agent and medicine that comprises ADAMTS13 as its main ingredient. This patent introduces a new use of ADAMTS13 in the clinical field. It provides methods for testing liver damage, hepatic ischemia/reperfusion injury, and liver function after transplantation. Each method involves measuring or monitoring the activity of ADAMTS13 in samples taken from mammals. Additionally, the patent includes an agent for treating diseases such as liver damage and hepatic dysfunction, which utilizes ADAMTS13 or its mutants as effective ingredients. He has 1 patent to his name.
Career Highlights
Throughout his career, Toyonari Kubota has been associated with prestigious institutions. He has worked at Kyoto University, where he contributed to various research initiatives. Additionally, he has been involved with Km Biologics Co., Ltd., further enhancing his expertise in the field of biotechnology.
Collaborations
Kubota has collaborated with notable colleagues, including Hirofumi Hirao and Shinji Uemoto. These partnerships have likely enriched his research and development efforts, leading to advancements in medical diagnostics.
Conclusion
Toyonari Kubota's work in the field of liver diagnostics exemplifies the impact of innovative thinking in medicine. His contributions through patents and collaborations continue to pave the way for advancements in healthcare.